We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP29306
Abstract: The contaminating DNA can originate from the PCR reagent manufacturing environment, raw materials, human operators, or host cells expressing recombinant proteins. The main source of DNA contamination is the enzyme used for PCR, i.e.,Taq DNA polymerase. Reported DNA removal methods vary in efficiency and may decrease the sensitivity of the assay. We introduce InvitrogenTM PlatinumTM Taq DNA Polymerase, DNA-free – a PCR enzyme with the lowest DNA contamination levels as compared to competing “DNA-free” enzymes. This was achieved through manufacturing innovation, where the enzyme is produced using a closed single-use system (SUS) to minimize the risk of DNA contamination inherent to the conventional manufacturing process.Summary: Polymerase chain reaction (PCR) technology, used for PCR-based assays, is fast, sensitive, and specific; however, uncontrolled DNA contamination in assays could compromise sensitivity and specificity.References: We would like to thank Eglė Merkienė for her support in
development of Platinum Taq DNA polymerase, DNA-free.
development of Platinum Taq DNA polymerase, DNA-free.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Activation of oncogenic PIK3CA induces serrated intestinal cancer
Meng Lei¹, Regina Chirst¹, Markus Tschurtschenthaler¹ and Dieter Saur¹
miniaturization and automation of CEL-Seq2 and SMART-Seq2 using the mosquito liquid handler
Josip Herman1, Jon Penterman2, Sagar1, Andreas Diefenbach3, Antigoni Triantafyllopoulou4, Anne F. Hammerstein5, Joby Jenkins5, Dominic Grün1, Stuart S. Levine2 and Klaus Hentrich5
ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda
Tres métodos moleculares para la genotipificación del virus de la Hepatitis C (VHC): una estrategia en pos de la seguridad del paciente
Andy Caballero, Sonali Marrero y Karla Montero
Comparación de tres pruebas moleculares para el diagnóstico y la evaluación de la resistencia a claritromicina de H. pylori en heces
Andy Caballero, Nelson Piñero